CVS Health Management

Management Kriterienprüfungen 3/4

CVS Health's CEO ist Karen Lynch , ernannt in Feb 2021, hat eine Amtszeit von 3.33 Jahren. Die jährliche Gesamtvergütung beträgt $21.62M , bestehend aus 6.9% Gehalt und 93.1% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.04% der Aktien des Unternehmens, im Wert von MX$569.13M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 2.3 Jahre bzw. 6.3 Jahre.

Wichtige Informationen

Karen Lynch

Geschäftsführender

US$21.6m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	6.9%
Amtszeit als Geschäftsführer	3.6yrs
Eigentum des Geschäftsführers	0.04%
Durchschnittliche Amtszeit des Managements	2.5yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	6.6yrs

Jüngste Management Updates

Recent updates

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Karen Lynch im Vergleich zu den Einnahmen von CVS Health verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Jun 30 2024	n/a	n/a	US$7b
Mar 31 2024	n/a	n/a	US$7b
Dec 31 2023	US$22m	US$2m	US$8b
Sep 30 2023	n/a	n/a	US$9b
Jun 30 2023	n/a	n/a	US$3b
Mar 31 2023	n/a	n/a	US$4b
Dec 31 2022	US$21m	US$1m	US$4b
Sep 30 2022	n/a	n/a	US$3b
Jun 30 2022	n/a	n/a	US$8b
Mar 31 2022	n/a	n/a	US$8b
Dec 31 2021	US$20m	US$1m	US$8b
Sep 30 2021	n/a	n/a	US$8b
Jun 30 2021	n/a	n/a	US$7b
Mar 31 2021	n/a	n/a	US$7b
Dec 31 2020	US$11m	US$1m	US$7b

Vergütung im Vergleich zum Markt: KarenDie Gesamtvergütung ($USD21.62M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt MX ($USD5.85M).

Entschädigung vs. Einkommen: KarenDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.

Geschäftsführer

Karen Lynch (61 yo)

3.6yrs

Amtszeit

US$21,615,034

Vergütung

Ms. Karen Sue Lynch serves as Chief Executive Officer, President and Director at CVS Health Corporation since February 01, 2021. She has extensive experience in the health care industry. She was Executive...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Karen Lynch	President	3.6yrs	US$21.62m	0.040% $ 588.4m
Thomas Cowhey	Executive VP & CFO	less than a year	US$4.58m	0.0028% $ 41.4m
Tilak Mandadi	Executive VP of Ventures and Chief Digital	2.2yrs	US$8.88m	0.0032% $ 46.9m
Samrat Khichi	Executive VP	1.6yrs	US$11.89m	0.00078% $ 11.4m
Prem Shah	Executive VP	2.8yrs	US$8.58m	0.0037% $ 54.4m
Vijay Patel	Senior Director of Business Development & CVS Health and Partner & Co-Founder	no data	keine Daten	keine Daten
James Clark	Senior VP	5.8yrs	keine Daten	0.00067% $ 9.8m
David Falkowski	Executive VP & Chief Compliance Officer	no data	keine Daten	keine Daten
Heidi Capozzi	Executive VP & Chief People Officer	no data	keine Daten	keine Daten
J. Joyner	Executive Vice President & President of CVS Caremark	1.7yrs	keine Daten	0.0032% $ 47.2m
Michelle Peluso	Executive VP and Chief Customer & Experience Officer	3.7yrs	keine Daten	0.0099% $ 144.6m
Joneigh Khaldun	VP & Chief Health Equity Officer	2.9yrs	keine Daten	keine Daten

2.5yrs

Durchschnittliche Betriebszugehörigkeit

57yo

Durchschnittliches Alter

Erfahrenes Management: CVS *Das Führungsteam des Unternehmens gilt als erfahren (2.3 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Karen Lynch	President	3.6yrs	US$21.62m	0.040% $ 588.4m
J. Kirby	Independent Director	less than a year	US$195.42k	0.00045% $ 6.6m
Roger Farah	Independent Chairman	5.8yrs	US$576.50k	0.00033% $ 4.8m
Mary Schapiro	Independent Director	7.3yrs	US$301.50k	0.00094% $ 13.7m
Nancy-Ann DeParle	Independent Director	11yrs	US$321.50k	0.0025% $ 37.0m
Anne Finucane	Independent Director	13.7yrs	US$321.50k	0.0026% $ 37.7m
C. Brown	Independent Director	17.5yrs	US$321.50k	0.0097% $ 141.1m
Jean-Pierre Millon	Independent Director	17.5yrs	US$321.50k	0.0088% $ 128.0m
Alecia DeCoudreaux	Independent Director	9.5yrs	US$301.50k	0.00024% $ 3.5m
Fernando Aguirre	Independent Director	5.8yrs	US$318.17k	0.0028% $ 41.0m
Jeffrey Balser	Independent Director	2yrs	US$301.50k	0.00058% $ 8.5m
Michael Mahoney	Independent Director	less than a year	US$167.50k	0.0011% $ 15.8m

6.6yrs

Durchschnittliche Betriebszugehörigkeit

67.5yo

Durchschnittliches Alter

Erfahrener Vorstand: CVS *Die Vorstandsmitglieder gelten als erfahren (6.3 Jahre durchschnittliche Amtszeit).

CVS Health Management

Management Kriterienprüfungen 3/4

Wichtige Informationen

Jüngste Management Updates

CVS Health Corporation Appoints Heidi Capozzi as Executive Vice President, Chief People Officer, Effective September 9, 2024

Insider recently bought Mex$8.5m worth of stock

CVS Health Corporation, Annual General Meeting, May 16, 2024

Executive VP recently sold Mex$39m worth of stock

CVS Health Announces Executive Changes

Independent Director recently bought Mex$2.5m worth of stock

Recent updates

Second quarter dividend of US$0.67 announced

CVS Health Announces Quarterly Dividend, Payable on November 1, 2024

Adherence Files Lawsuit Against CVS Health and Asembia for Alleged Unauthorized Use of Its Trademarked and Copyrighted Intellectual Property

CVS Health Announces Updated Flu and COVID-19 Vaccinations Now Available at CVS Pharmacy® and MinuteClinic®

CVS Health Corporation Appoints Heidi Capozzi as Executive Vice President, Chief People Officer, Effective September 9, 2024

Second quarter 2024 earnings released: EPS: US$1.41 (vs US$1.48 in 2Q 2023)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2024

CVS Health Corporation Launches First-Of-Its-Kind Initiative to Support Patients Most Vulnerable to Health Impacts of Extreme Weather Events

First quarter dividend of US$0.67 announced

CVS Health Announces Quarterly Dividend, Payable on August 1, 2024

Investor sentiment improves as stock rises 18%

Investor sentiment deteriorates as stock falls 19%

The Law Firms of Kessler Topaz Meltzer & Check, LLP and Carella, Byrne, Cecchi, Brody & Agnello, P.C. Files a Class Action Lawsuit Against CVS Health Corporation and Related Entities for Preventing SilverScript Members from Accessing Certain Generic Medications

Insider recently bought Mex$8.5m worth of stock

First quarter 2024 earnings released: EPS: US$0.88 (vs US$1.67 in 1Q 2023)

CVS Health Corporation Revises Earnings Guidance for the Full Year 2024

Upcoming dividend of US$0.67 per share

CVS Health Corporation, Annual General Meeting, May 16, 2024

CVS Health Corporation to Report Q1, 2024 Results on May 01, 2024

Fourth quarter dividend of US$0.67 announced

Cvs Health Approves Quarterly Dividend on the Common Stock, Payable on May 1, 2024

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Executive VP recently sold Mex$39m worth of stock

Full year 2023 earnings released: EPS: US$6.49 (vs US$3.16 in FY 2022)

Upcoming dividend of US$0.67 per share at 3.1% yield

CVS Health Corporation Provides Earnings Guidance for the Year 2023

CVS Health Announces Executive Changes

Robbins Geller Rudman & Dowd LLP and Aqualaw PLC Reaches Settlements in Class Action with Costco Wholesale Corporation, CVS Health Corporation, The Procter & Gamble Company, Target Corporation, Walgreen Co. and Walmart Inc

CVS Health Approves Quarterly Dividend, Payable on February 1, 2024

Independent Director recently bought Mex$2.5m worth of stock

CVS Health Names Mark Santos as President, Aetna Medicaid

CVS Health Corporation Revises Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings released: EPS: US$1.76 (vs US$2.60 loss in 3Q 2022)

CVS Health Announces Executive Changes

Upcoming dividend of US$0.60 per share at 3.4% yield

CVS Health Approves Quarterly Dividend, Payable on November 1, 2023

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter